The nuclear medicine community frequently experiences product shortages. Many of our customers report that they have been approached with offers of “compounded”
products
from various sources. We at NuTech, Inc. want to bring several issues regarding the use of
compounded products to
your attention to help you make an informed decision regarding these offers.
We at NuTech, Inc. want our patients to receive the very best
quality products available, therefore we have made
the decision to dispense only FDA approved radiopharmaceuticals and adjunct agents. Many drug shortages are due to manufacturing issues. If this is the case, compunding the product is not a legal option according to the FDA. If you are
considering
the use of "compounded" radiopharmaceuticals or adjunct agents in your practice, we suggest that you
read
the following before making a decision.
The Society of Nuclear Medicine published "The Use of Compounded Radiopharmaceuticals and Adjunct Drug Preparations."
Before your facility makes the decision to utilize "compounded" radiopharmaceuticals or adjunct agents, take this quiz to help you decide if this is the best decision for your facility and your patients.
A list of commercially approved radiopharmaceuticals, their approved manufacturers and their trade names is available. Nuclear medicine practitioners who receive any of the listed radiopharmaceuticals that originate from sources other than the identified manufacturers may be using unapproved copies. The list also highlights FDA-approved radiopharmaceuticals that may potentially have unapproved copies available in the marketplace.